Skip to main content
Equibles

Ikarian Capital, LLC

Position in TENX — Tenax Therapeutics, Inc.

CIK 1778253 DALLAS, TX
Back to TENX Full portfolio

Position in TENX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,459,580
-$4,811,844 QoQ
Shares Held
787,600
-22.6% QoQ
Ownership
2.10%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#7
of 111 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TENX Over Time

Shares Held

Position Value (USD)

Derivatives in TENX

reported options exposure · as of Jun 30, 2026
CallValue
$5,428,605
CallShares
373,100
PutValue
$240,075
PutShares
16,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. TENX ranks #13 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in TENX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,459,580 787,600
2026-06-30 $240,075 16,500
2026-06-30 $5,428,605 373,100
2026-03-31 $1,827,657 114,300
2026-03-31 $16,271,424 1,017,600
2025-12-31 $11,795,044 967,600
2025-09-30 $7,363,436 967,600